In the US, Bevacizumab (bevacizumab systemic) is a member of the drug class VEGF/VEGFR inhibitors and is used to treat Breast Cancer, Breast Cancer - Metastatic, Cervical Cancer, Colorectal Cancer, Fallopian Tube Cancer, Glioblastoma Multiforme, Hepatocellular Carcinoma, Macular Degeneration, Malignant Glioma, Neurofibromatosis, Non-Small Cell Lung Cancer, Ovarian Cancer, Pancreatic Cancer, Peritoneal Cancer, Renal Cell Carcinoma and Solid Tumors.
US matches:
- Bevacizumab
- Bevacizumab-adcd
- Bevacizumab-awwb
- Bevacizumab-bvzr
- Bevacizumab-maly
- Bevacizumab Injection
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
L01XC07
CAS registry number (Chemical Abstracts Service)
0216974-75-3
Chemical Formula
C6638-H10160-N1720-O2108-S44
Therapeutic Categories
Antineoplastic agent
Monoclonal antibody
Angiogenesis inhibitor
Vascular endothelial growth factor (VEGF) antagonist
Chemical Name
Immunoglobulin G1 (human-mouse monoclonal rhuMAb-VEGF gamma-chain anti-human vascular endothelial growth factor), disulfide with human-mouse monoclonal rhuMab-VEGF light chain, dimer (WHO )
Foreign Names
- Bevacizumabum (Latin)
- Bevacizumab (German)
- Bévacizumab (French)
- Bevacizumab (Spanish)
Generic Names
- Bevacizumab (OS: USAN)
- Bevacizumab (Genetical Recombination) (OS: JAN)
- anti-VEGF Mab (IS)
- Anti-VEGF monoclonal antibody (IS)
- rhuMAb-VEGF (IS)
- UNII-2S9ZZM9Q9V (IS)
- VEGF light chain, dimer (WHO) (IS)
Brand Names
- Altuzan Roche 100mg/4ml
Roche, Turkey - Altuzan Roche 400mg/16ml
Roche, Turkey - Avastin
Chugai Pharmaceutical, Japan; F. Hoffmann-La Roche, Macedonia; Genentech, United States; Hoffmann-La Roche, Canada; Hoffmann-La Roche Ltd, Latvia; Productos Roche, Chile; Roche, Armenia; Roche, Argentina; Roche, Bosnia & Herzegowina; Roche, Belgium; Roche, Brazil; Roche, Colombia; Roche, Cyprus; Roche, Czech Republic; Roche, Denmark; Roche, Ecuador; Roche, Estonia; Roche, Egypt; Roche, Spain; Roche, Finland; Roche, Georgia; Roche, Greece; Roche, Croatia (Hrvatska); Roche, Ireland; Roche, Israel; Roche, Italy; Roche, Lebanon; Roche, Lithuania; Roche, Moldova; Roche, Myanmar; Roche, Mexico; Roche, Norway; Roche, New Zealand; Roche, Philippines; Roche, Poland; Roche, Portugal; Roche, Paraguay; Roche, Romania; Roche, Russian Federation; Roche, Sweden; Roche, Thailand; Roche, Taiwan; Roche, Vietnam; Roche, South Africa; Roche D.O.O., Serbia; Roche Farma, Peru; Roche Pharmaceutical, China; Roche Products, Australia; Roche Registration, Netherlands; Roche Registration Limited, Iceland; Roche Registration, Slovenia; Roche Uruguay, Uruguay - Avastin 100mg/4ml
Roche, Oman; Roche Pharma Schweiz, Switzerland - Avastin 25 mg/ml
Abacus, Austria; Haemato Pharm, Austria; Inopha, Austria; Orifarm, Austria; Roche, Germany; Roche, France; Roche, Hungary; Roche Products, United Kingdom; Roche Registration, Austria - Avastin 400mg/16ml
Roche, Oman; Roche Pharma Schweiz, Switzerland - Avastin Roche
Roche, Hong Kong - Avastin-25
Roche, Luxembourg - Bevax
Elea, Argentina - Mvasi
Amgen, United States; Amgen Europe, Netherlands
Glossary
Term | Definition |
---|---|
IS | Inofficial Synonym |
JAN | Japanese Accepted Name |
OS | Official Synonym |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
USAN | United States Adopted Name |
Further information on drug naming conventions: International Nonproprietary Names.